Dear colleagues and friends,
We are honored to have been able to unite 3,000+ colleagues this year from around the world for our virtual event, “Moving the Needle on ALS & Neuromuscular Disorders,” on June 21st, 2022. Together we were able to enhance awareness and provide a global stage for key stakeholders to connect and collaborate to overcome barriers to finding cures for these devastating rare diseases.
This is our 9th episode of our “Collaborations That Transform” series. At WuXi AppTec, we are dedicated to providing a platform to catalyze transformational change for patients.
Special thanks to our more than 20 distinguished speakers, and to our supportive partners: ALS Association, Muscular Dystrophy Association, Motor Neurone Disease Association Singapore, and Beijing Oriental Rain ALS Care Center.
You are welcome to watch this event on-demand here: https://youtu.be/ITcuG6oD_KM
Thank you again, and make sure to follow us on Twitter and LinkedIn, and visit our WXPress website to stay up-to-date on upcoming WuXi AppTec news and events.
If you have any questions, please contact us at firstname.lastname@example.org.
AGENDA (The time below is AM, Pacific Daylight Time | Virtual via Zoom)
Hui Cai, Program Chair, VP & Head of Content, WuXi AppTec
Calaneet Balas, President & CEO, The ALS Association
Lin Kah Ooi, Founding President, Motor Neurone Disease Association Singapore
8:10 The Unmet Needs in Neuromuscular Disorders
Carsten Bönnemann, Senior Investigator, Neuromuscular & Neurogenetic Disorders of Childhood Section, NINDS
Matthew Harms, Associate Professor of Neurology, Institute for Genomic Medicine, Columbia University
Moderator: Sharon Hesterlee, Chief Research Officer, Muscular Dystrophy Association
8:40 Spotlight on ALS
Kuldip Dave, SVP of Research, The ALS Association
Sabrina Paganoni, Co-Director, Neurological Research Institute at Massachusetts General Hospital; Physician Scientist, Healey & AMG Center for ALS
Jeffrey Rothstein, Director of Brain Science Institute, Director, Robert Packard Center for ALS Research, Johns Hopkins University
9:10 In the Pipeline
Neil Cashman, CSO, ProMIS Neurosciences; Professor Emeritus, University of British Columbia
Michael McGrath, UCSF Emeritus Professor of Medicine; CSO & Founder, Neuvivo
Robert Scannevin, CSO, Verge Genomics
Fernando Vieira, CEO & CSO, ALS Therapy Development Institute
Moderator: Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie
9:50 Challenges and Opportunities in New Modalities
Jim Burns, CEO, Locanabio
Clive Svendsen, Professor & Executive Director, Board of Governors Regenerative Medicine Institute
Moderator: Bibhash Mukhopadhyay, Managing Partner, Sound Bioventures
10:20 The Future of Genetic and Personalized Medicines
Michael Snyder, Professor & Chair, Department of Genetics; Director, Center for Genomics and Personalized Medicine, Stanford University
10:25 Closing Remarks
Richard Soll, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec